1.0Shepherd & Allenhttps://saalawoffice.comrich600338<blockquote class="wp-embedded-content" data-secret="CEGCpIBcGy"><a href="https://saalawoffice.com/talc-johnson-johnson-may-may-not-get-dusted/">Talc: Why Johnson & Johnson May (or May Not) Get Dusted</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://saalawoffice.com/talc-johnson-johnson-may-may-not-get-dusted/embed/#?secret=CEGCpIBcGy" width="600" height="338" title="“Talc: Why Johnson & Johnson May (or May Not) Get Dusted” — Shepherd & Allen" data-secret="CEGCpIBcGy" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> https://saalawoffice.com/wp-content/uploads/2017/05/johnson-johnson-talc-lawsuit.jpg1024512Johnson & Johnson’s (JNJ: NYSE) “powder problem” just won’t go away. While the Company asserts that there is no connection between its products and ovarian cancer, jury after jury seems to disagree. The monetary awards to plaintiffs are mounting, but so far there has been no payout. So, what is the current state of JNJ’s […]